Free Trial

Blueprint Medicines (BPMC) Earnings Date, Estimates & Call Transcripts

→ Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad)
Free BPMC Stock Alerts
$93.00
+2.27 (+2.50%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 2
Before Market Opens
Confirmed
Actual EPS
(Feb. 15)
-$1.82 Beat By $0.22
Consensus EPS
(Feb. 15)
-$2.04
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

BPMC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BPMC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Blueprint Medicines Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243($1.89)($1.31)($1.67) 
Q2 20243($1.56)($0.88)($1.33) 
Q3 20243($1.43)($0.58)($1.14) 
Q4 20243($1.30)($0.34)($0.95) 
FY 202412($6.18)($3.11)($5.08) 
Q1 20251($0.87)($0.87)($0.87) 
Q2 20251($0.80)($0.80)($0.80) 
Q3 20251($0.83)($0.83)($0.83) 
Q4 20251($0.80)($0.80)($0.80) 
FY 20254($3.30)($3.30) ($3.30)

BPMC Earnings Date and Information

Blueprint Medicines last issued its earnings data on February 15th, 2024. The biotechnology company reported ($1.82) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.04) by $0.22. The business had revenue of $71.96 million for the quarter, compared to analysts' expectations of $67.34 million. Its revenue for the quarter was up 85.5% on a year-over-year basis. Blueprint Medicines has generated ($8.36) earnings per share over the last year (($8.36) diluted earnings per share). Earnings for Blueprint Medicines are expected to grow in the coming year, from ($5.41) to ($2.89) per share. Blueprint Medicines has confirmed that its next quarterly earnings report will be published on Thursday, May 2nd, 2024. Blueprint Medicines will be holding an earnings conference call on Thursday, May 2nd at 8:00 AM Eastern. Interested parties can register for or listen to the call..

Blueprint Medicines Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Confirmed)		-------  
2/15/2024Q4 2023($2.04)($1.82)+$0.22($1.82)$67.34 million$71.96 million    
10/26/2023Q3 2023($2.39)($2.20)+$0.19($2.20)$50.66 million$56.57 million    
8/2/2023Q2 2023($2.58)($2.19)+$0.39($2.19)$45.60 million$57.60 million    
5/4/2023Q1 2023($2.66)($2.15)+$0.51($2.15)$41.85 million$63.29 million    
2/16/2023Q4 2022($2.73)($2.65)+$0.08($2.65)$33.52 million$38.78 million    
11/1/2022Q3 2022($2.51)($2.23)+$0.28($2.23)$43.49 million$65.98 million
8/2/2022Q2 2022($2.23)($2.68)($0.45)($2.68)$37.61 million$36.55 million    
5/3/2022Q1 2022($1.79)($1.79)-($1.79)$39.98 million$62.70 million    
2/16/2022Q4 2021($0.71)($0.99)($0.28)$3.42$104.14 million$107.00 million    
10/27/2021Q3 2021($1.63)($2.00)($0.37)($2.00)$42.58 million$24.19 million    
7/28/2021Q2 2021($1.77)($1.86)($0.09)($1.86)$28.57 million$27.30 million    
4/28/2021Q1 2021($1.80)($1.72)+$0.08($1.72)$24.71 million$21.58 million  

Blueprint Medicines Earnings - Frequently Asked Questions

When is Blueprint Medicines's earnings date?

Blueprint Medicines has confirmed that its next quarterly earnings data will be published on Thursday, May 2nd, 2024. Learn more on BPMC's earnings history.

Did Blueprint Medicines beat their earnings estimates last quarter?

In the previous quarter, Blueprint Medicines (NASDAQ:BPMC) reported ($1.82) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.04) by $0.22. Learn more on analysts' earnings estimate vs. BPMC's actual earnings.

How can I listen to Blueprint Medicines's earnings conference call?

The conference call for Blueprint Medicines's latest earnings report can be listened to online. Listen to Conference Call

How can I read Blueprint Medicines's conference call transcript?

The conference call transcript for Blueprint Medicines's latest earnings report can be read online. Read Transcript

How much revenue does Blueprint Medicines generate each year?

Blueprint Medicines (NASDAQ:BPMC) has a recorded annual revenue of $249.38 million.

How much profit does Blueprint Medicines generate each year?

Blueprint Medicines (NASDAQ:BPMC) has a recorded net income of -$506.98 million. BPMC has generated -$8.36 earnings per share over the last four quarters.

What is Blueprint Medicines's EPS forecast for next year?

Blueprint Medicines's earnings are expected to grow from ($5.41) per share to ($2.89) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:BPMC) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
Banyan Hill Publishing
He Is Giving Away Bitcoin
Crypto Swap Profits
Fed launches fourth dollar overhaul
Stansberry Research
Biden out June 13; Kamala won’t replace him?
Paradigm Press